Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Silfradent
Santa Sofia, Emilia-Romagna, Italysilfradent.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Silfradent’s CGF platform and related medical devices are commercially available and used globally in dental surgery, implantology, bone-tissue regeneration procedures, and anti-aging therapies. The company collaborates with international research groups to develop protocols for growth factor activation and piezoelectric microsurgery. No clinical trial data typical of drug development companies; products are CE certified medical devices.
- Therapeutic areas
- RheumatologyOther
- Modalities
- DeviceAutologous blood component processing system
- Industry
- Surgical Medical Devices
02
Partnerships
Collaborations with European universities on periodontal researchInternational Research Excellence Group of doctors across specialties
Beyond the preview
Go deeper on Silfradent.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Silfradent.